未找到相关数据
Lack of impact of YMDD mutants on efficacy or safety of two years therapy with adefovir dipivoxil (ADV) in Chinese HBeAg positive chronic hepatitis B (CHB) patients
被引：0
作者：
Mao, Yi-Min
Zeng, Min-De
Zhou, Xia-Qiu
Wang, Hao
Ren, Hong
Niu, Jun-Qi
Dixon, Jonathan S.
Barker, Keith F.
机构：
[1] Renji Hosp, Shanghai, Peoples R China
[2] Ruijin Hosp, Shanghai, Peoples R China
[3] Beijing Peoples Hosp, Beijing, Peoples R China
[4] CMU 2nd Hosp, Chongqing, Peoples R China
[5] Jilin Univ, Hosp 1, Changchun 130023, Peoples R China
[6] GlaxoSmithKline R&D, Brentford, England
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A106 / A106
页数：1
相关论文